The latest international guidelines on urticaria were published in September as a joint initiative from the European Academy of…

THE ANNIVERSARY edition of the European Academy of Dermatology and Venereology’s (EADV) 30th Congress was held between 29th September and 2nd October 2021. As COVID-19 remains a barrier to global travel, the EADV’s 30th Anniversary Congress was staged virtually, providing access to the latest research, breakthroughs, and scientific advances to dermato-venereology professionals.

Recent years have witnessed significant advances in the understanding of facial anatomy. Extensive studies have uncovered the arrangement of soft-tissue layers underlying the skin and their mobility during expression. Meanwhile, increasing awareness of the facial vascular network has laid the foundation for lower risk cosmetic procedures.

One year after the identification of the novel severe acute respiratory syndrome 2 (SARS-CoV-2) infection in Wuhan, China, and the outbreak of the virus worldwide, the pandemic state persists, and the management of COVID-19 remains burdensome, with the number of people infected daily increasing progressively in most countries and the death rate being alarmingly elevated.1

An interview with Roxana Daneshjou, Clinical Scholar of Dermatology, Stanford University, California, USA.

Melanoma is a prominent type of skin cancer and treatment varies depending on the mutation and malignancy of the disease. The overall survival (OS) rate of metastatic melanoma is 35–50%. Pablo Fernandez-Peñas, Westmead Hospital, Sydney Medical School, Australia, opened the session by stating the discussion was based on BRAF-mutated melanoma. Fernandez-Peñas attested that targeted therapies are not beneficial for BRAF wild-type melanoma.

Tuberous sclerosis complex (TSC) is an autosomal dominant hereditary disease with hamartomatous growths in multiple organs due to…

During the COVID-19 outbreak, many countries imposed restrictive measures that resulted in unprecedented modifications in healthcare services.1 In several countries, including Greece, most of the public hospitals were practically transformed into COVID-19 units. In addition, public and health authorities repeatedly advised the population to avoid visiting hospitals during the pandemic outbreak. Moreover, social and sexual behaviour dramatically altered as a result of the strict social distancing measures.

Leishmaniasis is a widespread protozoan zoonosis transmitted by sandflies that can cause a wide range of clinical manifestations. Cutaneous leishmaniasis (CL) is the most common form, usually presenting as a small papule on an exposed skin area that enlarges and finally ulcerates. Therapies for CL are limited, and the systemic treatments available are hampered by toxicity and parasite resistance. As an alternative, photodynamic therapy (PDT) has been reported to be a safe and effective treatment for CL.1,2

When I was a medical student at the University of Oxford in England, UK, I enjoyed most clinical specialties but then I encountered dermatology and, for some reason, seeing diseases on the skin was something I enjoyed very much, as well as the complexity of it. I had always been drawn to clinical pictures in medical books of unusual syndromes. I am someone who wants to know why, so being able to conduct research was appealing as well as, initially, daunting. Furthermore, there were two very inspiring female academics at Oxford then, Fenella Wojnarowska and Sue Burge, who were great role models for me.